To the Editor:
A fully automated analyzer (Elecsys 2010 ® ) incorporates a new generation of electrochemiluminescence immunoassays (ECLIAs) (1) (2) (3) . At the core of the system is the ECL detection cell, which comprises three main parts: a magnet, a working electrode, and a photomultiplier. The streptavidin microparticles, coated with biotinylated antigen-antibody complexes, are deposited on the working electrode; the nonreactive particles, excess reagent, and sample are separated by flushing out through a buffer solution (ProCell) at pH 6.8. A voltage is then applied to the electrode, and emitted light is measured with the photomultiplier. A special cleaning solution (CleanCell) at pH 13.2 is used to wash the electrode surface; the measuring cell can then be regenerated by varying the potential on the electrode.
An optional BlankCell procedure corrects variations in the signal of the measuring cell and photomultiplier tube. This procedure uses two reagents: one is the same as that found in ProCell solution, and the second contains a defined quantity of ruthenium label. Given the stability of the signal, the manufacturer does not provide customers with protocol criteria as to when to perform this BlankCell procedure, but on the contrary, seems to recommend that it be carried out only by service personnel during the maintenance of the system.
We analyzed the effect of carrying out the BlankCell procedure daily for the measurement of thyroid hormones (thyrotropin, free thyroxine, and triiodothyronine). In April and May 1997, the assays were performed without BlankCell procedure, whereas in June 1997, the BlankCell procedure was carried out daily. We used Immunoassay Controls Comprehensive Tri-Level (Dade) to assess the imprecision (Level I, lot no. IAC1-129; Level II, lot no. IAC2-229; and Level III, lot no. IAC3-329) at the concentrations shown in Table 1 . Control Level III for triiodothyronine was discarded because the values obtained were Ͻ0.30 nmol/L.
The results for interassay reproducibility obtained in this study are shown in Table 1 . We observed significant differences (P Ͻ0.001, F Snedecor) of CVs between those months in which we worked without a daily BlankCell (April/May) and the month (June) when it was used. CVs were almost twice as low for thyrotropin and free thyroxine in the month of June, and the imprecision was particularly noticeable for triiodothyronine, where the CVs at the same concentrations decreased threefold.
Previous studies of Elecsys (4), do not address technical aspects that might improve the routine daily work. The life of the measuring cell would seem to depend on several factors; of these, the throughput and the sample material are the most important. In these conditions, the CleanCell solution may use up the measuring cell, and therefore, it appears reasonable to check its sensitivity by the BlankCell procedure. Diagnostic potential of thyrotropin assay as a first-line thyroid function test (5-6) may be improved with improved CVs. Although triiodothyronine is considered a second-line test in thyroid diseases, we observed high T 3 in patients receiving l-thyroxine therapy, perhaps reflecting conversion of T 4 to T 3 . This, together with use of T 3 in patients with nonthyroidal illness, suggests that the CVs for this hormone should also be improved. Given that the BlankCell procedure can be conducted in 5-6 min, we believe that the users of Elecsys 2010 will find it useful to produce considerable improvements in the quality of their results. The present data do not allow us to assess the relative values of use of the procedure on a weekly or monthly vs daily schedules.
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Representatives of Boehringer Mannheim respond:
To the Editor: Navarro et al. (1) report a significant improvement in interassay precision for three thyroid assays when performing a daily BlankCell procedure on the Boehringer Mannheim Elecsys ® Electrochemiluminescence Immunoanalyzer. The BlankCell procedure serves to calibrate the chemiluminescence signal received by the photomultiplier tube to a solution of known concentration. The procedure is now performed by Boehringer Mannheim service personnel on installation of the analyzer, as part of periodic maintenance, or as a troubleshooting tool. As such, the procedure also provides information about signal levels and ensures comparability of signal generation from instrument to instrument. Previously, a BlankCell measurement was performed automatically by the analyzer on a periodic basis. After assessing multiple analyzers and the entire assay menu, the benefit of a daily BlankCell could not be realized. Although a daily BlankCell may improve the precision in some cases (1) , internal data showed only marginal, adverse, or no improvement. By discontinuing the daily BlankCell, system availability is increased, while still providing our customers with an interassay precision that meets or exceeds immunoassay market standards. Navarro et al. (1) recommend the daily Blank-Cell procedure as a means of verifying that the measuring cell has not been "used up". There is no evidence that the measuring cell is consumed within the warranty of the lifetime of a measuring cell, (50 000 ECL cycles or 1 year, whichever comes first), under routine Elecsys operating conditions. We therefore feel the increased throughput, ease of operation, and reduced reagent costs associated with the discontinuation of the periodic BlankCell procedure, at minimal effect on assay precision, warrants its discontinuation.
